Protein kinase inhibitor therapeutics
Search documents
Inhibikase Therapeutics(IKT) - Prospectus
2024-06-18 21:27
Table of Contents As filed with the Securities and Exchange Commission on June 18, 2024. Registration No. 333-[●] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT (State or other jurisdiction of incorporation or organization) Delaware 2836 26-3407249 (Primary Standard Industrial Classification Code Number) 3350 Riverwood Parkway SE, Suite 1900 Atlanta, GA 30339 (I.R.S. Employer Identification Number) (678) 392-3419 (Address, including zip code, and tele ...
Inhibikase Therapeutics(IKT) - Prospectus(update)
2024-04-29 20:33
Table of Contents As filed with the Securities and Exchange Commission on April 29, 2024 Registration No. 333-278844 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INHIBIKASE THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2836 26-3407249 (Primary Standard Industrial Classification Code Number) 3350 Rive ...
Inhibikase Therapeutics(IKT) - Prospectus
2023-02-02 02:02
Table of Contents As filed with the Securities and Exchange Commission on February 1, 2023. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INHIBIKASE THERAPEUTICS, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2836 26-3407249 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Iden ...